Announcements

  • Bezlotoxumab May Cut Recurrent C. Diff in IBD

    7 years ago
    The human monoclonal antibody (Zinplava) appeared effective for treating recurrent Clostridium difficile infection () in patients with inflammatory bowel disease (IBD), researchers said.